Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients [Phase 2]

View source ↗

Summary

This clinical trial update notes ongoing Phase 2 evaluation of regorafenib plus best supportive care as maintenance therapy for high-grade bone sarcomas, and th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stivarga (regorafenib)

Snippet

Sponsor: Centre Leon Berard | Conditions: Bone Sarcoma, Osteosarcoma | Phase 2 | Status: RECRUITING